Skip to main content
. 2013 May;20(5):660–662. doi: 10.1128/CVI.00729-12

Table 2.

HBsAb concentrations in celiac patients (group A, 57; group B, 46; group C, 60) and in controls (48) vaccinated against hepatitis B

HBsAb titer Comparison group (no. [%]) Controls P
Group A vs controls
    <10 mIU/ml 25 (43.9) 4 (8.3) <0.001
    10–100 mIU/ml 14 (24.5) 9 (18.8) 0.17
    >100 mIU/ml 18 (31.6) 35 (72.9) <0.001
Group B vs controls
    <10 mIU/ml 16 (34.8) 4 (8.3) 0.002
    10–100 mIU/ml 20 (43.5) 9 (18.8) 0.009
    >100 mIU/ml 10 (21.7) 35 (72.9) <0.001
Group C vs controls
    <10 mIU/ml 35 (58.3) 4 (8.3) <0.001
    10–100 mIU/ml 18 (30) 9 (18.8) 0.131
    >100 mIU/ml 7 (11.7) 35 (72.9) <0.001